Many states have legalized the recreational use of marijuana in recent years, creating one of the more radical cultural shifts the United States has seen in quite some time. What could this trend mean from a cardiologist's perspective? 

The combination of AI and CT helped Nehal Mehta, MD, and colleagues track the performance of a new drug designed to target coronary inflammation. 

Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.

Researchers tracked data from more than 400,000 patients for a new meta-analysis, presenting their findings in the Journal of the American Heart Association.

The new device is believed to be the first of its kind, using both aspiration and mechanical clot disruption to remove blood clots.

Interventional cardiologist James B. Hermiller, MD, officially assumed the position at the end of SCAI 2024 Scientific Sessions.

The 61-year-old physician is currently in jail. He was previously in the news for allegedly implanting stents that were not medically necessary, agreeing to pay a hefty sum to settle.

One-year data presented at SCAI's annual meeting suggest interventional cardiologists could soon have a new way to treat severe aortic stenosis.

The popular AI chatbot's performance highlighted both its strengths and its weaknesses. It can answer multiple-choice questions, for example, but it struggles with consistency. 

TAVR is also associated with a lower risk of acute kidney injury in this patient population. In-hospital mortality rates, however, are similar between the two treatment options.